Nouveau Logo communiqué de presse.JPG
Theratechnologies fera une présentation à la conférence Cantor Fitzgerald Global Healthcare 2023
September 20, 2023 07:00 ET | Theratechnologies
MONTRÉAL, 20 sept. 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au point...
Nouveau Logo communiqué de presse.JPG
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
September 20, 2023 07:00 ET | Theratechnologies
MONTREAL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
Longboard Logo.jpg
Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
September 29, 2022 16:01 ET | Longboard Pharmaceuticals, Inc.
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
Nouveau Logo communiqué de presse.JPG
Theratechnologies participe à la conférence mondiale sur les soins de santé Cantor Fitzgerald le 29 septembre 2021
September 16, 2021 09:02 ET | Theratechnologies
MONTRÉAL, 16 sept. 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX : TH) (NASDAQ: THTX), une société biopharmaceutique axée sur le développement et la commercialisation...
Nouveau Logo communiqué de presse.JPG
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021
September 16, 2021 09:02 ET | Theratechnologies
MONTREAL, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of...
logo_new.jpg
ObsEva SA to Participate in Cantor Global Healthcare Conference October 2-4, 2019
September 27, 2019 01:00 ET | ObsEva SA
Geneva, Switzerland and Boston, MA – September 27, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...